In conclusion, we identified SPOCK1 as a novel TGF-β–induced MEC marker and further demonstrated that SPOCK1 enhanced invasion in breast cancer cells and correlated with poor prognosis in breast cancer clinical samples. The gene discussed is SPOCK1; the disease is breast carcinoma.